Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006
See this aricle in Pubmed

Article Abstract
In this proof-of-concept study, fingolimod reduced the number of lesions detected on MRI and clinical disease activity in patients with multiple sclerosis. Evaluation in larger, longer-term studies is warranted.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
fingolimod
gadolinium
immunomodulation
immunosuppressive agents
liver function enzymes
MRI
MRI,abnormal
MRI,contrast enhanced
MRI,serial
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
treatment of neurologic disorder

Click Here to return To Results